Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/08/24
End: 08/30/27
Due: 08/30/28
Phase: N/A
Priority: Normal
Start: 08/03/22
End: 01/31/26
Due: 01/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis | NCT06479863 | Austin Neuromuscular Center | user2@example.com | None | 2024-08-08 | 2027-08-30 | 2028-08-30 | - | - | 2025-07-14 |
| Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy | NCT05023889 | Austin Neuromuscular Center | user2@example.com | None | 2022-08-03 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |